Survival TRaining for ENhancing Total Health (STRENGTH)
A Phase II Randomized Study to Assess the Feasibility of Distance Medicine Based Exercise and Dietary Approaches to Prevent Body Composition Change Occurring During Adjuvant Chemotherapy for Early Stage Breast Cancer
1 other identifier
interventional
39
1 country
4
Brief Summary
RATIONALE: A home-based exercise and/or diet program may improve the quality of life of breast cancer patients by preventing an increase in body fat and weight and a loss of lean body tissue. PURPOSE: This randomized phase II trial is studying the effectiveness of three home-based diet and/or exercise programs in preventing weight gain and loss of muscle tissue in women who are receiving chemotherapy for stage I, stage II, or stage IIIA breast cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2 breast-cancer
Started Sep 2003
Shorter than P25 for phase_2 breast-cancer
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2003
CompletedFirst Submitted
Initial submission to the registry
September 10, 2003
CompletedFirst Posted
Study publicly available on registry
September 11, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2004
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2005
CompletedDecember 19, 2017
April 1, 2013
4 months
September 10, 2003
December 15, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Distance Medicine Based Diet Exercise Program Within the Cooperative Group Setting
Assess estimates of effect sizes and to ascertain potential feasibility of implementing a distance-medicine based diet-exercise program within the cooperative group setting.
6 months
Study Arms (3)
Arm 1: calcium diet
ACTIVE COMPARATORCalcium-Rich Diet (dietary counseling + materials promoting an intake of 1,200 - 2,500 mg/day).
Arm 2: Exercise + Calcium-Rich Diet
ACTIVE COMPARATORExercise + Calcium Rich Diet (dietary counseling + materials promoting strength training and aerobic activity + a calcium intake of 1,200 - 2,500 mg/day).
Exercise + Fruit & Vegetable, Low Fat + Calcium Diet
ACTIVE COMPARATORDietary counseling + materials promoting strength training and aerobic activity + a diet that has \< 20% of energy coming from fat and intakes of fruits and vegetables of \> 5 servings/day + a calcium intake of 1,200 - 2,500 mg/day. 6 month intervention.
Interventions
1,200 - 2,500 mg/day. 6 month intervention
Dietary counseling + material promoting strength training an aerobic activity + a calcium intake of 1,200 - 2,500 mg/day. 6 month intervention.
1,200 - 2,500 Calcium intake per day. 6 month intervention period.
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- Duke Universitylead
- National Cancer Institute (NCI)collaborator
Study Sites (4)
Duke Comprehensive Cancer Center
Durham, North Carolina, 27710, United States
Southeastern Medical Oncology Center
Goldsboro, North Carolina, 27534, United States
Comprehensive Cancer Center at Wake Forest University
Winston-Salem, North Carolina, 27157-1030, United States
Cancer Centers of the Carolinas - Eastside
Greenville, South Carolina, 29615, United States
Related Publications (1)
Demark-Wahnefried W, Case LD, Blackwell K, Marcom PK, Kraus W, Aziz N, Snyder DC, Giguere JK, Shaw E. Results of a diet/exercise feasibility trial to prevent adverse body composition change in breast cancer patients on adjuvant chemotherapy. Clin Breast Cancer. 2008 Feb;8(1):70-9. doi: 10.3816/CBC.2008.n.005.
PMID: 18501061RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Edward G. Shaw, MD
Wake Forest University Health Sciences
- PRINCIPAL INVESTIGATOR
Wendy Demark-Wahnefried, PhD
Duke Cancer Institute
- STUDY CHAIR
Roger T. Anderson, PhD
Wake Forest University Health Sciences
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 10, 2003
First Posted
September 11, 2003
Study Start
September 1, 2003
Primary Completion
January 1, 2004
Study Completion
January 1, 2005
Last Updated
December 19, 2017
Record last verified: 2013-04